UPS Healthcare™ Cold Chain brings a full suite of end-to-end cold chain capabilities to customers worldwide
ATLANTA – UPS (NYSE: UPS) is expanding its speciality pharmaceutical services by establishing UPS Healthcare™ Cold Chain, a comprehensive suite of cold chain technologies, best-in-class capabilities, and new and expanded global facilities providing complete, end-to-end temperature-controlled logistics.
"Our customers have been benefitting from our cold chain capabilities for many years, but the pandemic caused UPS to move even faster to enhance an integrated set of cold chain solutions to support the future of the pharmaceutical and medical device industry," said Wes Wheeler, UPS Healthcare President. "UPS' near-perfect, on-time delivery of the COVID-19 vaccine proves how effectively and efficiently our network handles biologically derived medicines, even at extreme temperatures."
Chronic and life-threatening diseases, including cancers, respiratory, autoimmune and cardiovascular conditions, are the fastest growing disease categories in the world, creating a rapid acceleration in the development of biologically derived, temperature-controlled medicines and therapies.
According to the Biopharma Cold Chain Sourcebook, cold chain trends show 48 percent growth between 2018 and 2024 for medicines that require at least 2 to 8 degrees Celsius storage and shipping. Additionally, the overall market for cold chain services (packaging, transportation and data services) is expected to significantly accelerate growth over the next three years, growing by 24 percent by 2024, after posting a 10 percent increase from 2019 to 2020.
"The future of the healthcare and speciality pharmaceutical industries will increasingly rely on robust cold chain networks to safely deliver temperature-controlled medicines and therapies to customers," said Kate Gutmann, UPS Chief Sales and Solutions Officer and SVP, UPS Global Healthcare. "The continued evolution of our cold chain services ensures UPS is ready for the future and can continue to provide long-term value for our healthcare customers."
UPS Healthcare™ Cold Chain is purpose-built to provide pharmaceutical companies, healthcare providers and laboratories with a full, end-to-end cold chain service offering, including storage and distribution, transportation, visibility, and quality assurance capabilities, to meet their complex demands for critical products around the world.
As part of a continued, aggressive strategy to build sophisticated capabilities in cold chain logistics, UPS Healthcare is expanding and augmenting its temperature-controlled products and services, including:
"UPS sets a high bar for excellence in cold chain delivery and logistics, and these current and future investments in innovative solutions will ensure we keep pushing the bar higher," Wheeler said. "For our customers, we will remain focused on delivering on our commitment to Quality Focused. Patient Driven." You can find out more about UPS Healthcare™ Cold Chain and other UPS Healthcare initiatives by visiting: www.ups.com/healthcare.
UPS Healthcare delivers unparalleled healthcare logistics expertise to its customers around the world. UPS Healthcare has 11+ million square feet of cGMP and GDP-compliant healthcare distribution space globally. Its services include inventory management, cold chain packaging and shipping, storage and fulfilment of medical devices, and lab and clinical trial logistics. UPS Healthcare's global infrastructure, its UPS® Premier visibility service, its track and trace technology, and its global quality system are well-suited to meeting today's complex logistics demands for the pharmaceutical, medical device, and laboratory diagnostic industries.
UPS delivers COVID-19 vaccines to Asia's most populous country
Equitable vaccine initiative
UPS Healthcare to expand its European cold chain capabilities